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Abstract
Studying the biophysical characteristics of glycosylated proteins and solving their three-dimensional structures requires
homogeneous recombinant protein of high quality.We introduce here a new approach to produce glycoproteins in
homogenous form with the well-established, glycosylation mutant CHO Lec3.2.8.1 cells. Using preparative cell sorting,
stable, high-expressing GFP ‘master’ cell lines were generated that can be converted fast and reliably by targeted
integration via Flp recombinase-mediated cassette exchange (RMCE) to produce any glycoprotein. Small-scale transient
transfection of HEK293 cells was used to identify genetically engineered constructs suitable for constructing stable cell lines.
Stable cell lines expressing 10 different proteins were established. The system was validated by expression, purification,
deglycosylation and crystallization of the heavily glycosylated luminal domains of lysosome-associated membrane proteins
(LAMP).
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Introduction
Structural and biophysical studies of glycosylated proteins
require recombinant protein samples of high quality and
homogeneity. Production of glycoproteins relies mostly on
eukaryotic protein expression systems [1]. Protein-linked glycan
chains are essential for protein folding and secretion, but they
cause sample heterogeneity, which complicates protein crystalli-
zation and biophysical measurements, e.g. determination of
molecular mass and oligomerization status [2]. Inhibitors and
mutations of N-acetylglucosaminyl-transferase I (GnTI) prevent
the processing of N-linked glycans beyond the high-mannose
type, leading to smaller and more homogeneous modifications
[3,4]. GnTI-negative HEK293 and CHO Lec [3] cell lines
have enabled the crystallization of a number of glycoproteins
[5,6,7]. High-mannose type glycans can be truncated efficiently to
a single N-acetylglucosamine by endoglycosidase H, which usually
does not affect protein stability, but often improves crystal growth
[4,8].
Stable cell lines with good performance have integrated the
recombinant transgene at a genetically stable hot spot of
transcription. Preparative fluorescence-activated cell sorting
(FACS) is very efficient for isolating such cell lines [9,10,11,12]
and was applied by us previously to glycosylation mutant CHO
cells for crystallization of glycoproteins [8]. However, preparative
sorting of CHO cells growing in suspension can be challenging,
especially if cell lines for several target proteins have to be
established in parallel. Therefore, in this study, we combined cell
lines carrying a fluorescent marker at a hot spot of transcription
with targeted gene integration, thus allowing to derive production
cell lines for arbitrary proteins from the same fluorescent master
cell line in a single step (Fig. 1A).
Genome engineering by recombinase-mediated cassette ex-
change (RMCE) allows targeted integration of transgenes precisely
into defined expression hot spots of the host cell genome [13,14].
RMCE with the recombinase Flp requires a master cell line
‘tagged’ at such a hot spot by a reporter gene cassette flanked by
Flp recognition target (FRT) sites. The flanking FRT sites, the wild
type and a synthetic variant, cannot recombine with each other.
RMCE is achieved by co-transfecting the tagged master cell line
with a targeting vector containing the gene of interest, flanked by
the same pair of FRT sites, and a Flp expression vector (Fig. 1A). A
double-reciprocal crossover of the FRT sites leads to an exchange
of the reporter with the gene of interest in the host cell genome.
RMCE is thus practically irreversible, in contrast to recombination
systems that use only a single recombination site [15,16]. For
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2 Decemantibiotic selection of recombinant cell lines, RMCE has been
combined with a selection trap, consisting of a truncated antibiotic
resistance marker that becomes complemented by the recombi-
nation event [17].
In the present study, GFP-positive master cell lines were
established by preparative cell sorting that allows integrating genes
of interest by RMCE with selection trap (Fig. 1A). Stable
production cell lines for 10 different proteins were established,
including members of the heavily glycosylated lysosome-associated
membrane protein (LAMP) family. The system was validated by
expression, purification, deglycoslation and crystallization of
different LAMP luminal domains.
Results
Glycosylation mutant RMCE master cell lines
Stable RMCE master cell lines were derived from the CHO
Lec3.2.8.1 glycosylation mutant [3] by transfection with the
vector pEFFS-EGFP-dneo (Fig. 1B) that contains a GFP reporter
gene under control of the human elongation factor 1a (EF)
promoter (Fig. 1). The GFP gene is flanked by the wild type FRT
site (F) and the synthetic variant F3. A selection trap, an ATG-
deleted, promoterless neomycin phosphotransferase (Dneo) gene
is located downstream of GFP. When GFP is exchanged by Flp-
mediated recombination against a cassette including a promoter
and start codon, Dneo becomes complemented and the cell
becomes resistant against the antibiotic G418, thus allowing for
selection of recombinant cells.
CHO Lec3.2.8.1 cell clones with stable genome integration of
pEFFS-EGFP-dneo were isolated by two rounds of preparative
FACS. The 2.6% most highly fluorescent cells were isolated one
week post transfection (Fig. 2A). One week later, 11% of the
isolated cells had retained strong fluorescence and were again
isolated by FACS. Transfection and sorting was repeated once and
1.1% and 5% of the cells were isolated in the first and second
round of FACS, respectively. 30 cell clones obtained from each
transfection were cultured for 12 weeks and 15 cell clones with
stable GFP expression and favourable growth characteristics were
finally isolated (Fig. 2A,B).
Multiple integrated transgene copies can lead to irreproducible
results in RMCE. Therefore, the number of genetic loci bearing
the pEFFS-EGFP-dneo transgene was determined by Southern
blot (Fig. 2C) and the presence of tandem repeat concatemers was
tested by PCR (Fig. 2D). Two out of seven tested cell lines were
found to contain a single copy of the transgene (SWI3a-26,
SWI3b-5, Table 1).
Exchange of GFP against RFP
GFP was exchanged in seven master cell lines against a red
fluorescent protein (RFP) gene by RMCE, performed by co-
transfecting the master cell lines with an expression plasmid for the
highly active Flp variant FLPo [18,19] and the exchange vector
Figure 1. Strategy and vector maps. (A) Strategy for establishing production cell lines by RMCE. The tagging vector contains an EF promoter (P)
controlling the expression of a GFP gene flanked by a set of heterospecific FRT sites, the synthetic variant F3 and the wild-type F. A silent, ATG-
deficient neomycin resistance (Dneo) gene allows selection of targeted cells. (1) CHO Lec3.2.8.1 host cells are transfected with the tagging vector.
GFP-tagged cells are isolated by two rounds of FACS. (2) Cassette exchange is initiated by co-transfecting a tagged cell line with a Flp expression
vector and a targeting vector bearing the gene of interest (GOI) and a PGK promoter (P) destined to complement the Dneo gene. These genetic
elements are flanked by FRT sites compatible to the tagging vector. Thus, the transiently expressed Flp recombinase exchanges the tagging gene
cassette. New production cell clones with chromosomally integrated GOI are selected by G418. (B) The tagging and targeting vectors used in this
study. SP=signal peptide.
doi:10.1371/journal.pone.0027829.g001
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PGK lacks a promoter and was inactive until it was positioned by
recombination adjacent to the EF promoter present in the master
cells (Fig. 1). Upon recombination, a PGK promoter and a start
codon located on the exchange vector activated the Dneo gene at
the tagged locus. Resistant colonies were obtained at a frequency
of about 3610
25 (40–50 colonies from 1.5610
6 transfected cells).
Several resistant cell clones were isolated per master cell line and
red fluorescence was detected by FACS, which was stable over at
least five weeks (Fig. 3B). The RFP cassette was detected in all
subclones by PCR (Fig. 3C). Of the five master cell lines carrying
multiple copies of the GFP transgene, two gave rise to subclones
that had retained GFP copies in their genome, indicating
incomplete RMCE (Fig. 3C, Table 1). These GFP gene copies
were obviously inactive as green fluorescence was not detectable.
GFP was absent in RFP clones derived from the other three
multi-copy master cell lines, indicating that all of the two or three
GFP copies present in these cells were exchanged in the RMCE
reactions (Table 1). Random integration of the RFP exchange
plasmid or the Flp expression vector was not detected by
Southern blot and PCR analysis of 5 and 12 subclones,
respectively (data not shown).
GFP and RFP expression of seven master cell clones and their
corresponding subcell clones was quantified (Fig. 3D). GFP from
four-day master cell cultures varied between 11 and 30 mg/l
according to fluorescence spectroscopy of cell extracts (Table 1).
GFP concentrations corresponded well to flow cytometry
intensities. Subclones of the same origin produced similar
amounts of RFP, as expected for isogenic cells (Fig. 3D). The
two master cell lines containing transgene concatemers, SWI3a-
22 and SWI3a-23, gave rise to cell lines with notably low RFP
expression, which can be explained by the reduction of the
concatemers to single copies during the recombination reaction.
RMCE with the remaining five master cell lines, although these
produced different amounts of GFP, resulted in subcell clones
expressing similar amounts of RFP. This suggests that factors
other than transcriptional activity limited the maximal RFP
concentration in this cell type.
Figure 2. Generation of master cell lines. (A) Selection of CHO Lec3.2.8.1 cells upon transfection with the GFP tagging vector pEF-FS-EGFP-dneo.
One week post transfection, the top 2.6% fluorescent cells were isolated. Of these cells, the top 11% fluorescent cells were isolated as single cells one
week later. The fluorescence profile of a representative cell clone is shown. (B) Fluorescence profile of a representative tagged cell clone in
comparison to parental CHO Lec3.2.8.1 cells (marked with ‘C’). The GFP fluorescence of the tagged cells was observed over 12 weeks without
measuring a reduction in fluorescence strength. (C) Southern blot analysis of integrated tagging vector copy numbers in six potential master cell
clones. Genomic DNA was digested by BamHI, blotted and probed for GFP. Multiple bands indicate integration at multiple chromosomal sites.
(D) PCR test for concatemers in four potential master cell clones. Primers are marked by horizontal arrows in panel C. PCR products were obtained
only in the presence of tandem repeats. Cones=FRT sites (dark=F3, light=wild type).
doi:10.1371/journal.pone.0027829.g002
Table 1. Recombination and production properties of different master cell clones and RFP subclones.
Master cell clones SWI3a-22 SWI3a-23 SWI3a-26 SWI3a-33 SWI3b-5 SWI3b-18 SWI3b-25
Transgene copy number 2 2 1 3 1 3 2
Concatemers yes yes no no no no no
GFP concentration [mg l
21] 1 91 41 21 12 03 02 1
Proportion of subclones
retaining GFP after RMCE
0/6 2/5 0/3 6/6 0/2 0/2 0/3
doi:10.1371/journal.pone.0027829.t001
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Most production cell lines were derived from master cell line
SWI3a-26, which was genetically stable, carried a single-copy
transgene of high transcriptional activity, performed well in
RMCE and gave rise to highly fluorescent RFP subclones. Cell
lines for 10 different target proteins were established to produce
protein for crystallization, including members of the family of
lysosome associated membrane proteins (LAMPs). The LAMPs’
large N-terminal portion is highly glycosylated and resides in the
lysosomal lumen. It is composed of two similar domains, which
are connected by a proline-rich, flexible hinge. A set of 33 LAMP
domains of different species was cloned into the mammalian
expression vector pEFFS-sigHA with a C-terminal hemagglutinin
(HA) tag for immunodetection (Table S1). HEK293 and CHO
Lec3.2.8.1 were transiently transfected and secreted proteins were
detected by immunoblotting (data not shown). Five sequences
were selected for construction of stable cell lines: the full luminal
region of human and mouse LAMP-2 (termed ‘hLAMP2-lum’
and ‘mLAMP2-lum’), the membrane-proximal domain of human
LAMP-3, also known as DC-LAMP (‘hLAMP3-prox’) and the
membrane-distal domains of mouse and rat LAMP-2 (‘mLAMP2-
dist’, ‘rLAMP2-dist’). In addition, cell lines were generated for an
engineered single chain (sc) variant of hepatocyte growth factor
(HGF, also known as scatter factor), hamster prion protein (PrP),
high affinity IgE receptor subunit a (FceRIa), c-interferon
inducible lysosomal reductase (GILT) and NALP3 (Fig. 4).
RMCE was performed as described for RFP. Depending on the
construct, the optimal mass ratio of co-transfected targeting vector
and Flp-expression vector was 1:4, 2:3 and 1:1, corresponding to a
molar ratio of about 1:2. Four subclones were typically expanded
for each construct, and RMCE was confirmed by PCR.
Recombinant protein production by correctly targeted cell clones
was analyzed by Western blot (Fig. 4). Sublones derived from the
same RMCE reaction expressed their transgene at a similar level,
as expected for isogenic cells. With the exception of NALP3 cell
clones, recombinant protein yield appeared adequate for produc-
ing at least10 mg of purified protein in a 22 litre bioreactor run.
This amount allows for extensive crystallization screening and
optimization. NALP3 is an intracellular protein that was solubly
produced and detected in small amounts by an anti-His antibody
(Fig. 4B) and by an anti-NALP3 antibody (data not shown) as well.
An scHGF cell clone with high productivity and acceptable
growth was chosen for further analysis. The clone produced
1.460.4 pg per cell per day (pcd) in 40 ml spinner flasks, similar to
a previously described scHGF cell clone derived from a Flp-
mediated reporter gene excision system [8] (SWI4_25a; 1.060.2
pcd) and considerably more than a conventionally established cell
clone for wild-type HGF [20] (EGT92/A20; 0.560.1 pcd).
Protein production and crystallization
Batches of up to 50 litre conditioned medium were produced by
perfusion bioprocessing to obtain sufficient amounts of protein for
crystallization. An scHGF production cell line derived by RMCE
(SWI3a-26a) secreted 32 mg of the growth factor into 22.5 litre
conditioned medium produced in perfusion mode. hLAMP3-prox
and mLAMP2-dist were produced in the same way. From
22.5 litre culture supernatant, 27 mg hLAMP3-prox or 15 mg
mLAMP2-dist were obtained upon diafiltration, affinity chroma-
tography and gel filtration (Fig. 5A). mLAMP2-dist was deglyco-
sylated with endoglycosidase H, subjected to sparse matrix
crystallization screening and crystals were obtained (Fig. 5B).
However, X-ray diffraction of the crystals tested so far was not
sufficient to proceed with crystallographic analysis (Fig. 5A).
Highly diffracting crystals of hLAMP3-prox had been described
previously [8] and were also obtained from the protein produced
by the RMCE cell line under the same conditions. Deglycosylation
Figure 3. Exchange of GFP with RFP by RMCE. (A) Green fluorescence of a GFP-tagged master cell clone (green), a GFP-negative RFP subclone
(red) and CHO Lec3.2.8.1 cells (grey). (B) Red fluorescence of an RFP subcell clone upon one-week (orange) and 5-week (red) cultivation, compared to
the corresponding master cells (grey). (C) Verification of RMCE by PCR amplification of the FRT-flanked gene cassette (GFP 1.9 kb, RFP 2.7 kb) from
chromosomal DNA of cell lines derived from a master cell line with multi-copy transgenes. Lanes 1–5 and M represent 5 representative RFP positive
subcell clones and the master cell line. Cell lines with incomplete exchange of integrated GFP gene copies were detected in lanes 1 and 3. (D)
Expression strength of 7 GFP master cell clones and 2–4 corresponding RFP targeted subcell clones. Intracellular GFP (green) and RFP (red)
fluorescence was measured by flow cytometry. GFP fluorescence was scaled down by a factor of 10.
doi:10.1371/journal.pone.0027829.g003
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protein with intact glycosylation.
Discussion
In this study, we describe glycosylation mutant master cell lines
that reduce time and effort for high-quality stable cell line
development. The combination of preparative cell sorting and
RMCE was successful and is applicable to other mammalian cell
line types as well. RMCE was applied for the first time to establish
glycosylation mutant cell lines for protein production for X-ray
crystallography.
Master cell lines with single-copy transgenes were established
that performed reliably in RMCE with RFP targeting vector. A
promoter trap and a neomycin selection trap assured that the GFP
reporter gene was absent in all the resulting cell clones (Fig. 1). A
targeting frequency of about 3610
25 was sufficient for robust
generation of new production cell lines. Isolating large numbers of
clones was not necessary since all targeted cell clones were isogenic
and produced recombinant proteins at the same level.
Genetically stable, highly productive cell lines were reliably
obtained that produced glycoproteins with limited glycosylation,
amenable to enzymatic deglycosylation. Fig. 6 shows the time scale
of establishing recombinant RFP cell lines by RMCE, which took
7 weeks from the day of transfection to cryopreservation of clonal
production cell lines. Protein production with stable cell lines was
scaled up reproducibly to large volumes according to the required
amounts of protein. LAMP domains that could be produced well
by stable cell lines were identified successfully by small scale, high-
throughput transient transfections.
RMCE with three master cell lines with multiple integrated
transgenes resulted in complete exchange of all reporter gene
copies to RFP. Obviously, simultaneous exchange at distinct loci
had taken place in these cells. Simultaneous exchange at different
loci has also been described recently in the context of multiplexing
of RMCE with a novel set of synthetic FRT variants [21].
Previously, we established scHGF and hLAMP3-prox produc-
tion cell lines by preparative cell sorting followed by Flp-mediated
excision of the reporter [8]. scHGF cell lines established by RMCE
had a similar, slightly higher specific productivity as these
previously reported cells. Productivity was also similar in the case
of the LAMP-3 domain. In comparison to the reporter gene
excision approach, RMCE was considerably faster and more
predictable. Fewer clones had to be analyzed and preparative cell
sorting was not required.
In conclusion, the system presented here simplifies generation of
producer cell lines for homogenous glycoproteins. We demonstrate
a strategy that combines high-throughput screening of genetic
constructs by transient transfection with rapid establishment of
stable cell lines. Large-scale protein production allowed purifica-
tion and deglycosylation of milligram amounts of protein. High
protein quality and homogeneity was proven by successful
crystallization.
Materials and Methods
Plasmid construction
Coding sequences of 33 LAMP domains were cloned by PCR
into the vector pEFFS-sigHA (GenBank HQ333206) between the
vector encoded signal peptide and HA-tag sequences using the two
Esp3I restriction sites of the vector. PCR products were either
Figure 4. Recombinant protein expression by production cell
lines derived by cassette exchange. (A) Immunoblots of superna-
tants containing secreted recombinant glycoproteins. Molecular
weights were calculated without signal peptides, glycosylations and
GPI-anchors. The number of glycosylation sites is indicated (glyco.).
Each lane represents a different subcell clone. Four subcell clones are
shown for each protein with the exception of mLAMP2-dist, for which
only one subcell clone was isolated. (B) Western blot of cell lysates of
four NALP3 targeted subcell clones. Small amounts of recombinant
human NALP3 were detected in all four soluble lysate fractions of the
targeted cells, but not in the SWI3a-26 master cells (C). i=insoluble,
s=soluble.
doi:10.1371/journal.pone.0027829.g004
Figure 5. Protein purification and crystallization of LAMP
domains. (A) Purified mLAMP2-dist with intact glycosylation (lane 1),
deglycosylated mLAMP2-dist (lane 2) and deglycosylated mLAMP2-dist
purified by gelfiltration (10 mg in lane 3 and 5 mg in lane 4) were
analysed by SDS-PAGE and Coomassie staining. Additional mLAMP2-
dist bands in lane 2 might have been caused by incomplete reduction
of disulphide bonds. (B) Crystals of mLAMP2-dist.
doi:10.1371/journal.pone.0027829.g005
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tails including Esp3I, Eco31I or BpiI sites that lead to sticky ends
compatible to the vector upon digestion (Tables S1, S2).
The tagging vector pEF-FS-EGFP-dneo (GenBank JF313342) is
based on pEF-FS-EGFP and contains GFP under control of the
human EF1a promoter. The GFP gene is flanked by one synthetic
(F3) and one wild type FRT site. An ATG-deleted neomycin
phosphotransferase (Dneo) gene [22] was PCR amplified with
primers 59-TAGATGCATG CTCGAGCGAC TCTAGAGGAT
CCCCCGA-39 and 59-AGGAACTTCG GAATTCAGTG
GATTGCACGC AGGTTC-39 and cloned between the EcoRI
and XhoI sites of pEF-FS-EGFP with the In-Fusion cloning system
(Clontech, Saint-Germain-en-Laye, France). For the construction
of targeting vectors, the EF1a promoter was deleted by cutting
pEF-FS-EGFP with BglII and HindIII, blunting the overhangs
and ligating the free ends. Sequences encoding a signal peptide
and a His-tag were cloned between the FRT sites, replacing GFP,
resulting in pFS-sigHis. To obtain pFS-sigHis-PGK (GenBank
JF313343), a PGK promoter and an ATG start codon [9,23] were
inserted upstream of the wild type FRT site to complement the
inactive Dneo gene after targeting. pFS-RFP-PGK and the
NALP3 exchange vector contain the open reading frames of
dsRed RFP (GenBank ABB83400) or human NALP3 between the
NcoI and MluI sites of pFS-sigHis-PGK. The following genes were
cloned between the BpiI sites of pFS-sigHis-PGK for RMCE:
human scHGF, human GILT (Swiss-Prot P13284), hLAMP3-prox
(GenBank AAH32940), hLAMP2-lum, mLAMP2-lum, rLAMP2-
prox, hamster PrP, the ectodomain of human high affinity IgE
receptor a chain (FceRIa) or human NALP3. The transgenes
include a C-terminal His6-tag and a mouse immunoglobulin signal
peptide (Swissprot P01750).
Cell culture and transfection
A HEK293-6E cell line constitutively expressing the EBNA1
protein of EBV wasobtained from the Canadian National Research
Council, Montreal, Canada and was cultivated and transfected as
described [21]. The glycosylation mutant CHO Lec3.2.8.1 cell line
[3] was kindly provided by Dr. Pamela Stanley, Albert Einstein
College of Medicine, New York. The cell line was adapted to
growth in suspension in ProCho5 medium (Lonza, Cologne,
Germany) supplemented with 11 mg/ml phenol red in spinner
flasks at 37uC, 5% CO2 and 80 rpm or in multi-well plates at 37uC,
5% CO2 and 150 rpm on an Incutec K15-500 linear shaker
(Barsbu ¨ttel, Germany). Cell numbers and viability were assayed by
trypan blue dye exclusion method.
Plasmid DNA for transfection was purified with the EndoFree
Plasmid Maxi Kit (Qiagen, Hilden, Germany). The tagging vector
pEF-FS-EGFP-dneo was linearized with SalI followed by
purification with the Plasmid Extract II Kit (Macherey-Nagel,
Du ¨ren, Germany). 1.5610
6 cells in 2 ml medium were transfected
with 1–5 mg linearized plasmid DNA by using program U-24 of
the Amaxa nucleofection device according to manufacturer’s
guidelines (Lonza, Cologne, Germany; Nucleofector
TM Kit V).
24 h post transfection the medium was exchanged and the cells
were seeded into 6-well plates and cultivated at 37uCi na
humidified atmosphere with 5% CO2 at 150 rpm. In the following
days, the transfected cell cultures were expanded before entering
the stationary phase.
Flow cytometry and preparative FACS
CHO Lec3.2.8.1 cells were transported and sorted at room
temperature. GFP expression was analyzed with a Guava Easy-
Cyte Mini System (Guava Technologies, Hayward, CA, USA).
Cells were stained with 50 mg/ml propidium iodide to exclude
dead cells from the analysis. Preparative FACS was performed on
a MoFlo high-speed cell sorter (Beckman Coulter, Krefeld,
Germany). The sorter was equipped with an argon-ion laser
tuned to 488 nm with 100 mW of power and an automated cell
deposition unit for sorting into 96-well plates. GFP fluorescence
was detected through a 530/40-nm bandpass filter. Data analysis
was performed using CytoSoft 4.2 and WinMDI 2.9 software.
RMCE
The cassette exchange in tagged CHO Lec3.2.8.1 cells was
performed by Amaxa nucleofection (Lonza, Cologne, Germany;
Nucleofector Kit V). Production cells lines were derived from
SWI3a-26, except for LAMP2-lum and hLAMP3-prox cell lines,
which were derived from SWI3a-33. The cells were co-transfected
with 1 mg, 2 mg or 2.5 mg of the targeting vector and 4 mg, 3 mgo r
2.5 mg of the optimized FLPo [18] expression vector Flpo-puro
[23], respectively. The FLPo expression vector pPGKFLPobpA
(Addgene plasmid 13793) was also used successfully. 24 h post
transfection, the cells were seeded on a 100 mm culture dish in
10 ml CD-Hybridoma medium and cultivated at 37uCi na
humidified atmosphere with 8% CO2. To select for the targeted
subcell clones, 2 mg/ml G418 was added 4–5 days post
transfection. Medium was replaced every three to four days until
the subcell clones were picked in 96 well plates after two to three
weeks. GFP negative cell colonies were expanded and recloned by
serial dilution, if necessary. Clonal cell lines were adapted to
suspension cultures in serum free ProCho5 medium (Lonza,
Cologne, Germany) by adding 10 U/ml heparin (Sigma, Stein-
heim, Germany) during the first 2 passages.
Southern blotting
Genomic DNA was analyzed by Southern blotting to identify
the copy number of the integrated transgene. 10 mg chromosomal
CHO DNA was digested with appropriate restriction enzymes and
separated in 0.8% agarose gels together with a digoxigenin-
labelled DNA molecular weight marker II (Roche, Mannheim,
Germany) and transferred to Hybond N
+ membranes (Amersham,
Munich, Germany) o.n. by capillary transfer with 206SSC buffer.
Figure 6. Timeline for RFP cell line development by RMCE. Following transfection, selection and subcloning, cells were analyzed by flow
cytometry (FC) and PCR analysis to confirm the cassette exchange. Recombinant protein production was controlled with Western blots (WB) before
cryopreservation of the cell clones. It took 7 weeks from transfection of the master cells to cryopreservation of the first aliquot of RFP cell clones.
doi:10.1371/journal.pone.0027829.g006
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DNA was fixed to the membrane by UV-crosslinking. Hybridisa-
tion and immunological detection was performed with DIG High
Prime DNA Labeling and Detection Starter Kit II (Roche,
Mannheim, Germany). A 755 bp GFP fragment, a 457 bp KpnI/
PacI fragment from Flpo-puro [21] and a 667 bp NgoMIV/SacI
of pFS-scHGF-PGK were used as hybridization probes for GFP,
FLPo and PGK promoter sequences, respectively.
PCR-based analysis of genomic DNA
Genomic DNA was isolated with an AquaGenomic
TM kit
(MoBiTec, Go ¨ttingen, Germany). For detection of integrated
concatemers, PCRs were performed with primers specific for the
tagging vector pEF-FS-EGFP-dneo (59-GCAGCCAGGG GCGT-
GGAAGT AATTCAAGG-39,5 9-TCACATGGTC CTGCTG-
GAGT TCGTGACCG-39) and pointing towards the ends of the
linearized vector. Thus, only chromosome-integrated vector
concatemers gave rise to a PCR product with these primers.
Following RMCE, exchange of the GFP marker was confirmed by
PCR amplification of the FRT-flanked gene cassette with primers
59-TCGGGAGATC TCGACCGAGC TTTGCAAA-39 and 59-
TGCTCGAGCG GCCGCTCTAG AACTAGTGGA-39. All
PCRs were performed with 50 ng chromosomal DNA and the
Expand High Fidelity PCR System (Roche, Mannheim, Ger-
many).
Fluorescence spectrometry
GFP concentration in RMCE master cell extracts was
quantified by fluorescence spectroscopy with an Infinite M1000
fluorescence microplate reader (Tecan, Ma ¨nnedorf, Switzerland).
1.5610
5 cells/ml were seeded in 3 ml in 6-well plates or in 40 ml
in spinner flasks. Fluorescence from the cell extracts was measured
(excitation 470 nm, emission 510 nm) in non-fluorescent micro-
titer plates (Nunc, Langenselbold, Germany) using several
dilutions of the samples, and was converted to 0.1–1 mg/ml
standard curve of recombinant GFP standard (BioVision,
Mountain View, CA, USA).
ELISA
HGF product titres were quantified with the human HGF
DuoSet ELISA Development System (R&D Systems, Abingdon,
UK) and productivity per cell was calculated as described [8].
Western blotting
Intracellular proteins were extracted by the Cytobuster
TM
protein extraction reagent (Novagen, Darmstadt, Germany). Cells
expressing PrP conjugated to a GPI-anchor were solubilised in
10% (w/v) PBS supplemented with a protease-inhibitor cocktail
(Roche, Mannheim, Germany) and 5 mM MgCl2 using a Dounce
homogenisator. For Western Blot analysis, PrP lysates were treated
with 400 kU/ml DNaseI (Roche, Mannheim, Germany).
Stable cell culture supernatants and PrP cell lysates were
analyzed by 12% SDS-PAGE and Western blotting with a goat
anti-HGF antibody (dilution 1:1,000, R&D Systems, Abingdon,
UK) for scHGF, a mouse anti-PrP antibody (dilution 1:5,000,
Prionics, Schlieren, Switzerland) for PrP and an anti-His antibody
(dilution 1:1,000, Novagen, Darmstadt, Germany) for all other
proteins. The anti-HA antibody 12CA5 (1:5,000, Roche) was used
for transiently transfected cell supernatants. Detection was done
with the respective secondary antibodies conjugated to an alkaline
phosphatase (1:2,000, Promega, Mannheim, Germany) or a
horseradish peroxidase (1:2,000, Dianova, Hamburg, Germany),
before development with BCIP-NBT solution (Applichem, Darm-
stadt, Germany) or Super Signal West Pico chemiluminescent
substrate (Thermo Scientific, Bonn, Germany), respectively.
Purification and deglycosylation of LAMP domains
Production cell lines were cultivated in stirred tank bioreactors
in perfusion mode and hLAMP3-prox and mLAMP2-dist were
purified by nickel ion affinity chromatography and gelfiltration, as
described previously [8]. mLAMP2-dist gelfiltration fractions in
10 mM HEPES-NaOH, pH 7.4, 150 mM NaCl were diluted to
20 mM NaCl with 20 mM Tris-HCl, pH 7.4 and loaded on a
Mono Q anion exchange column. mLAMP2-dist was collected in
the flow through and concentrated to 1.5 mg/ml with a 10 K
Vivaspin concentrator (Sartorius Stedim Biotech, Go ¨ttingen,
Germany). Domains were deglycosylated with a fusion of
endoglycosydase H and maltose binding protein (Endo Hf, New
England Biolabs Inc., Beverly, MA, USA) and gelfiltrated again, as
described [8]. mLAMP2-dist was deglycosylated at 1 mg/ml in
100 mM Na-acetate, pH 5.2, with 50 units Endo Hf per mg
mLAMP2-dist.
Crystallization
hLAMP3-prox was crystallized as described [8]. Crystallization
screens for mLAMP2-dist were set up manually in 24-well format
by preparing hanging drops of 200 nl protein at 25 mg/ml in
(10 mM HEPES, pH 7.4, 150 mM NaCl) with an equal volume of
reservoir buffer of the JCSG+ screen (Qiagen). Single crystals were
obtained in 2 ml droplets composed of 1 mL 22 mg/ml protein and
1 ml of reservoir buffer (0.1 M citrate-phosphate buffer, pH 4.2,
40% (v/v) PEG 300). Diffraction data were acquired by an X-ray
home source (Rikagu, Sevenoak, UK) and at beamline X12 at the
EMBL outstation (Hamburg, Germany).
Supporting Information
Table S1 Details of LAMP expression constructs.
(PDF)
Table S2 Sequences of the primers listed in Table S1.
(PDF)
Acknowledgments
We are grateful to Ju ¨rgen Bode, Andre ´ Oumard, Roland Schucht and Paul
Saftig for valuable discussions and providing materials. We thank Sarah
Tokarski and Nadine Konisch for excellent technical assistance and Sandra
Broll for providing the GFP probe.
Author Contributions
Conceived and designed the experiments: KB SW. Performed the
experiments: SW KB VW MG JJ AD LP LG. Analyzed the data: KB
SW. Contributed reagents/materials/analysis tools: DW DWH JVH VJ
RJO. Wrote the paper: KB SW.
References
1. Aricescu AR, Assenberg R, Bill RM, Busso D, Chang VT, et al. (2006)
Eukaryotic expression: developments for structural proteomics. Acta
Crystallogr D Biol Crystallogr 62: 1114–1124.
2. Butters TD, Sparks LM, Harlos K, Ikemizu S, Stuart DI, et al. (1999) Effects of
N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan
processing in Chinese hamster ovary cells: application to glycoprotein
crystallization. Protein Sci 8: 1696–1701.
3. Stanley P (1989) Chinese hamster ovary cell mutants with multiple glycosylation
defects for production of glycoproteins with minimal carbohydrate heterogene-
ity. Mol Cell Biol 9: 377–383.
Cell Lines for Glycoprotein Crystallization
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e278294. Chang VT, Crispin M, Aricescu AR, Harvey DJ, Nettleship JE, et al. (2007)
Glycoprotein Structural Genomics: Solving the Glycosylation Problem.
Structure 15: 267–273.
5. Reeves PJ, Callewaert N, Contreras R, Khorana HG (2002) Structure and function in
rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-
glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative
HEK293S stable mammalian cell line. Proc Natl Acad Sci U S A 99: 13419–13424.
6. Niemann HH, Ja ¨ger V, Butler PJ, van den Heuvel J, Schmidt S, et al. (2007)
Structure of the human receptor tyrosine kinase met in complex with the Listeria
invasion protein InlB. Cell 130: 235–246.
7. Aricescu AR, Siebold C, Choudhuri K, Chang VT, Lu W, et al. (2007) Structure
of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp
mechanism. Science 317: 1217–1220.
8. Wilke S, Krausze J, Gossen M, Groebe L, Jager V, et al. (2010) Glycoprotein
production for structure analysis with stable, glycosylation mutant CHO cell
lines established by fluorescence-activated cell sorting. Protein Sci 19:
1264–1271.
9. Nehlsen K, Schucht R, da Gama-Norton L, Kromer W, Baer A, et al. (2009)
Recombinant protein expression by targeting pre-selected chromosomal loci.
BMC Biotechnol 9: 100.
10. Qiao J, Oumard A, Wegloehner W, Bode J (2009) Novel tag-and-exchange
(RMCE) strategies generate master cell clones with predictable and stable
transgene expression properties. J Mol Biol 390: 579–594.
11. Kaufman WL, Kocman I, Agrawal V, Rahn HP, Besser D, et al. (2008)
Homogeneity and persistence of transgene expression by omitting antibiotic
selection in cell line isolation. Nucleic Acids Res 36: e111.
12. Mattanovich D, Borth N (2006) Applications of cell sorting in biotechnology.
Microb Cell Fact 5: 12.
13. Turan S, Galla M, Ernst E, Qiao J, Voelkel C, et al. (2011) Recombinase-
Mediated Cassette Exchange (RMCE): Traditional Concepts and Current
Challenges. Journal of Molecular Biology In Press.
14. Wirth D, Gama-Norton L, Riemer P, Sandhu U, Schucht R, et al. (2007) Road
to precision: recombinase-based targeting technologies for genome engineering.
Curr Opin Biotechnol 18: 411–419.
15. Baer A, Bode J (2001) Coping with kinetic and thermodynamic barriers: RMCE,
an efficient strategy for the targeted integration of transgenes. Current Opinion
in Biotechnology 12: 473–480.
16. Schlake T, Bode J (1994) Use of mutated FLP recognition target (FRT) sites for
the exchange of expression cassettes at defined chromosomal loci. Biochemistry
33: 12746–12751.
17. Verhoeyen E, Hauser H, Wirth D (2001) Evaluation of retroviral vector design
in defined chromosomal loci by Flp-mediated cassette replacement. Hum Gene
Ther 12: 933–944.
18. Raymond CS, Soriano P (2007) High-efficiency FLP and PhiC31 site-specific
recombination in mammalian cells. PLoS One 2: e162.
19. Kranz A, Fu J, Duerschke K, Weidlich S, Naumann R, et al. (2010) An
improved Flp deleter mouse in C57Bl/6 based on Flpo recombinase. genesis 48:
512–520.
20. Gherardi E, Sandin S, Petoukhov MV, Finch J, Youles ME, et al. (2006)
Structural basis of hepatocyte growth factor/scatter factor and MET signalling.
Proc Natl Acad Sci U S A 103: 4046–4051.
21. Schirrmann T, Bu ¨ssow K (2010) Transient production of scFv-Fc fusion proteins
in mammalian cells. In: Kontermann R, Du ¨bel S, eds. Antibody Engineering.
Heidelberg: Springer-Verlag GmbH. pp 387–400.
22. Schucht R, Coroadinha AS, Zanta-Boussif MA, Verhoeyen E, Carrondo MJ,
et al. (2006) A new generation of retroviral producer cells: predictable and stable
virus production by Flp-mediated site-specific integration of retroviral vectors.
Mol Ther 14: 285–292.
23. Turan S, Kuehle J, Schambach A, Baum C, Bode J (2010) Multiplexing RMCE:
Versatile Extensions of the Flp-Recombinase-Mediated Cassette-Exchange
Technology. J Mol Biol 402: 52–69.
Cell Lines for Glycoprotein Crystallization
PLoS ONE | www.plosone.org 8 ember 2011 | Volume 6 | Issue 1 | e27829 2 Dec